TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmetheus AB
Closing information (x1000 EUR)
| Closing information | 2023/11 | 2022/11 | 2021/11 |
| Turnover |
16,778
|
13,711
|
10,218 |
| Financial expenses |
9
|
9
|
10 |
| Earnings before taxes |
4,307
|
3,523
|
2,144 |
| EBITDA |
4,354
|
3,573
|
2,196 |
| Total assets |
8,971
|
6,724
|
4,105 |
| Current assets |
8,689
|
6,602
|
3,996 |
| Current liabilities |
3,539
|
2,719
|
1,788 |
| Equity capital |
5,053
|
3,608
|
2,092 |
| - share capital |
6
|
6
|
6 |
| Employees (average) |
71
|
61
|
55 |
Financial ratios
| Fiscal year | 2023/11 | 2022/11 | 2021/11 |
| Solvency |
56.3%
|
53.7%
|
51.0% |
| Turnover per employee |
236
|
225
|
186 |
| Profit as a percentage of turnover |
25.7%
|
25.7%
|
21.0% |
| Return on assets (ROA) |
48.1%
|
52.5%
|
52.5% |
| Current ratio |
245.5%
|
242.8%
|
223.5% |
| Return on equity (ROE) |
85.2%
|
97.6%
|
102.5% |
| Change turnover |
3,672
|
4,138
|
1,328 |
| Change turnover % |
28%
|
43%
|
15% |
| Chg. No. of employees |
10
|
6
|
13 |
| Chg. No. of employees % |
16%
|
11%
|
31% |
Total value of public sale
| Fiscal year | 2023/11 | 2022/11 | 2021/11 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.